
Professor
MB206B
Department of Molecular Biology, The Scripps Research
Institute
Department of Molecular Biology MB2
The Scripps Research Institute,
10550 North Torrey
The Scripps Research Institute
Damon Runyon Cancer Research Foundation
858 784 2223
858 784 2224
858 784 9822
The two major long-term themes in my research are:
the
understanding of how the amino acid sequence of a protein determines its final
folded structure.
the
understanding of enzyme and protein function through study of structure and
dynamics.
Primary research techniques include NMR spectroscopy for
study of structure and dynamics, mass spectrometry, and equilibrium and kinetic
CD and fluorescence spectroscopy. Molecular cloning techniques have been an
extremely powerful addition to the arsenal, allowing us to prepare labeled
proteins in the amounts necessary for structural studies by NMR. (Bracketed
numbers refer to references in the publications list).
The initial steps in protein folding are the most relevant
for the exploration of the link between sequence and folded structure. They are
also the most difficult to study experimentally. We tackled this problem by
using short peptide fragments of proteins as a model system for the earliest
events in the folding process. The initial focus of this work was to determine
the sequence specificity for residual structure in short peptides in solution,
as a model system for secondary structure propensities in unfolded proteins
that might act as folding initiation sites. Reverse turns were found to be highly
sequence-dependent (Refs 9, 47, 87 from the Publication List), and in some
cases contained a sufficiently high population of turn conformations that the
structure of the turn could be calculated (48). In order to determine which
parts of proteins potentially contained folding initiation sites, three large
sets of peptides were studied, corresponding to the complete sequences (in
pieces) of Themiste zostericola
myohemerythrin (31, 75), French bean plastocyanin (32) and sperm whale
myoglobin (35-37, 72). These studies remain the definitive work in this field.
More recently the emphasis has been on the use of new NMR techniques to probe
residual structure in denatured forms of the full-length protein.
NMR is the method of choice for the examination of the
solution conformational ensembles of equilibrium folding intermediates and
unfolded states of proteins. This work represents a major thrust of research in
my group at the present time and is conducted in an equal collaboration with
Dr. Peter E. Wright. We have succeeded in assigning the backbone resonances for
acid-unfolded apomyoglobin (127) and for low-salt unfolded plastocyanin (132).
The chemical shift indices reveal differences in the backbone conformational
ensemble between the two proteins, which indicate that apomyoglobin populates a backbone conformations, while plastocyanin
populates b. This result is entirely
consistent with the previously-published peptide studies. In addition, the extremely
exciting observation of anomalies in the dynamics of the acid-unfolded form of
apomyoglobin has led to the hypothesis that these indicate transient contacts
between the termini of the protein. Further work using spin-labeled
apomyoglobin (manuscript in preparation) has verified these observations and
supported the hypothesis: these results provide the first experimental
observation of the initial events in the collapse of a protein during folding.
The most exciting aspect is that the collapse appears to be specific – only
those areas of the molecule that are involved in the folding intermediate and
present in the final folded structure are found to be in transient contact in
the acid-unfolded form.
There are no published studies of the structure of a folding
intermediate. X-ray crystallography is impossible due to the fluxional nature
of such intermediates, and, while NMR is obviously the method of choice, none
of the recognized intermediates of other proteins such as lactalbumin give good
NMR spectra. The apomyoglobin intermediate appears to be an exception, with
excellent NMR spectra. This work has been published (82,112).
Folding experiments on apomyoglobin using quench-flow
methods combined with mass spectrometry (94) provide definitive evidence that
this protein folds by a single major pathway, and that the observed folding
intermediate is obligatory. The folding pathway has been further characterized
by the study of several mutants, including a double mutant where the H helix is
destabilized (95) and a mutant where the E helix is stabilized by the
replacement of the functional distal histidine with a phenylalanine (117).
Recent mutant studies have focused on the B helix region, where changes have
been made at a number of positions, resulting in the stabilization of the
protein in some cases and destabilization in others. Kinetic and thermodynamic
studies on these mutants reveal a fascinating variety of folding mechanisms,
even though the mutant proteins differ in only one or two residues. Two manuscripts
are in preparation on this work.
The question as to whether the folding pathway of a protein
family is conserved if the structure is preserved, or whether the folding
pathway depends more critically on details of the amino acid sequence has been addressed
by comparing two proteins, leghemoglobin and myoglobin, which are very similar
in structure but have very low sequence homology. In this case, it is found
that, while both proteins fold via early formation of a helical burst phase
intermediate, there are major differences in the constitution of this
intermediate according to details of the amino acid sequence differences
between them (115, 203).
The Escherichia coli chaperone DnaJ contains a number of domains whose functions have been mapped, but for which structural information is sketchy. The cysteine-rich (CR) domain of DnaJ was thought to contain zinc binding sites, and the spacing and number of the cysteines was thought to indicate that it would fold as a classic zinc-finger domain. We cloned and expressed the CR domain of DnaJ, and determined the solution structure by NMR (116). It proved to form a novel fold incorporating two zinc ions and 6 short b-strands in an overall V-shaped b-hairpin structure. The difference between this structure, which is associated with chaperones which bind polypeptides, and those of the DNA-binding zinc fingers is probably related to the difference in the function.
A fruitful collaboration with Ursula Jakob at the University of Michigan on the structure of a redox-regulated chaperone, Hsp33, resulted in the publication of two papers (165, 170) that delineate the order-disorder transition that accompanies the change from zinc-bound reduced monomer (inactive) to zinc-free oxidized dimer, incorporating a disordered C-terminal tail. This system illustrates an intriguing connection between redox chemistry on the one hand and protein disorder on the other.
Folding switches have also been of great interest, in particular the folding-related signals involved in bacterial quorum sensing. A small-molecule autoinducer (frequently an acyl homoserine lactone) is required for folding of the quorum-sensing protein. In the absence of the autoinducer, the molecule does not fold; when the autoinducer is present (a signal that other individual bacteria are in the vicinity) the protein folds, and is subsequently able to perform its function as a transcriptional activator for genes that are upregulated in the presence of a threshold number (“quorum”) of individual bacteria. Our contribution to this field was an examination of the intriguing quorum-sensing protein SdiA of E. coli, which was identified by sequence homology with better-known quorum-sensing proteins such as LuxR from the bioluminescent organism Vibrio fischeri. Our structure of SdiA (185) is very similar to that of LuxR – our interest in this protein was sparked by the absence in the E. coli genome of a gene coding for the enzyme that synthesizes the autoinducer, which suggests that E. coli uses the quorum sensing mechanism to detect members of other bacterial species rather than members of its own species.
Our interest in chaperone-protein interactions has been
extended to an examination of the bacterial ribosome-bound chaperone trigger factor
(197) and we have recently embarked on a major program to elucidate the
interactions between the chaperone Hsp90 and its co-chaperones and client
proteins by NMR (189, 204).
It has recently been shown that a number of protein systems
are unfolded or only partly folded until they bind ligand or substrate. While
this has been known for many years to apply to peptide hormones, we now realize
that certain transcription factors, cyclin-dependent kinase inhibitors and other
proteins are unfolded in the absence of their natural receptors. In addition,
folding processes have been implicated in a number of disease states, such as
Alzheimer’s Disease and the prion diseases such as kuru and bovine spongiform
encephalopathy (“mad cow” disease). We have been involved in the structure
elucidation of some of the fragments of the prion protein (a collaboration with
Drs. Fred Cohen and Stan Prusiner at UCSF). This promising new field has
already given us hints that the state of folding of the fragments will be
crucial in the conversion between cellular and infectious forms of the prion
protein. A paper has been published on the structure and dynamics of the long
fragment (PrP29-231) of the hamster prion protein (79). A recent new direction
has been the exploration of the binding of Cu(II) to repeated sequences (termed
“octarepeats”) in this fragment, which appear to bind this metal exclusively
and highly specifically (96). A detailed examination of the dynamics of two
fragments of the Syrian hamster prion protein (PrP90-231 and PrP29-231) (125)
revealed a number of anomalous features that are related to the presence of two
domains, one folded and one unfolded, in the same molecule. This work will have
wide applicability in the study of other systems with significant proportions
of unfolded structure. More recently, we have been engaged in the structure
determination of a prion protein homologue present in tissues other than the
brain. This protein, termed Doppel, has a similar overall fold to that of the
prion protein, but differences in local structure suggest that its function may
differ significantly (126).
An invited review synthesizing our recent thoughts on
unfolded, functional proteins has appeared (100). We have also made a number of
studies of baseline NMR parameters that can be used particularly in the studies
of unfolded and partly folded proteins, but which are applicable also to the
rapid elucidation of secondary structure in folded proteins. These include
proton (56) and backbone 13C and 15N (119) random coil
chemical shifts, and methodology and tabulations for the correction of backbone
random coil chemical shifts for the effects of local sequence (130). Sequence
correction of random coil chemical shifts has been an important missing factor
in the more accurate prediction of secondary structure from chemical shifts,
and the method developed in our laboratory appears to be widely applicable and
particularly useful for 13CO shifts. These methods have been
integrated into a widely used NMR analysis program, and are referred to on the
Web site of the NMR data depository BioMagResBank.
A number of protein systems have been studied to elucidate the
link between chemistry, structure, dynamics and function. The system that has
been studied the longest in my laboratory is E. coli thioredoxin, a long-standing collaboration with Professor
Arne Holmgren of the Karolinska Institute,
A major recent effort has gone into the determination of the
structure of another member of the thioredoxin-glutaredoxin family, E. coli glutaredoxin-2 (Grx-2). This
protein is present in large quantities in the bacterial cell, but was not
detected in earlier assays for glutaredoxin since it has no activity in the
ribonucleotide reductase assay, the original screen for glutaredoxins. Until
recently its primary function has been a mystery, but our collaborator in
A clear relationship between structure and function was seen
for another system, a metalloprotein obtained from an acidophilic bacterium. Thiobacillus ferrooxidans rusticyanin
has the astonishing property that it contains a highly stable Type I or “blue”
copper site at pHs well below 4. In fact the protein is stable and functional
in sulfuric acid at pH 0.5, in spite of a copper coordination site that
includes two histidines, which would normally be protonated at such a low pH.
The solution structure of reduced rusticyanin (69), obtained utilizing a novel
method of gene synthesis (58,77) clearly shows that the acid-stability of
rusticyanin resides in the composition of the environment of the copper site,
which contains a high proportion of aromatic groups, causing steric hindrance
to the dissociation of the ligand histidines. Further collaborative work with
Dr. Chris Bender has resulted in new approaches to the pulsed EPR of
copper-containing proteins (78).
The relationship between dynamics of the polypeptide chain and enzyme catalysis is being explored. The success of structure-based drug design has so far been quite modest. This may be because the design process incorporates only static structural information. Our working hypothesis is that a requirement for efficient enzyme catalysis may well be that the active site be flexible, and that enzymes have therefore evolved to incorporate this flexibility. To test this hypothesis we will use mutagenesis coupled with full characterization of changes in enzymatic function, structure and dynamics. As an initial approach to the subject, two very different enzyme systems are being studied, in collaboration with Dr. Peter Wright: dihydrofolate reductase, for which we already have clear evidence that dynamics play a role in catalysis, and a metallo-b-lactamase for which there is evidence from the crystal structure of flexibility in the active site region. Both of these enzymes are clinically important potential targets for anti-cancer drugs in the case of DHFR and to combat antibiotic resistance in the case of the metallo-b-lactamase. Our approach should be exceptionally powerful in elucidating the role of dynamics in catalysis. A number of papers have been published on the preliminary NMR characterization of the metallo-b-lactamase system (89, 90,104) and a paper describing the dynamics of the system in the presence and absence of a tight-binding inhibitor has been published (120). Further work on this system will include the characterization of mutant proteins designed to explore the role of a “flexible flap” over the active site cleft in the catalytic mechanism and in allowing a broad range of substrate specificity.
One of the central molecular interactions in cellular
control is the NF-kB/IkBa
interaction. The inhibitor molecule, IkBa, consists of a series of ankyrin repeats,
which appear to have differential mobility. In collaboration with a group
associated with Professor E. A. Komives of UCSD, we have made an NMR study of
the dynamics of IkBa free and in complex with NFkB. Our studies indicate that the
differential mobility of the ankyrin repeat subunits is functional (205) and
that the intrinsically unstructured
The function of a number of clinically important systems
requires interactions between proteins. NMR provides a particularly sensitive
tool for exploration of such interactions. We have been concerned for many
years with the question of the immunogenicity of peptides (in collaboration
with Drs. Richard Lerner and Ian Wilson). A hypothesis that immunogenic
peptides may have a higher-than-usual propensity for folded conformations in
solution (8) has been explored by studying the solution conformational
preferences of an extensive series of such peptides (3, 8, 9, 10, 20, 25, 28,
29, 40, 67,70). These studies have added greatly to our understanding of the
nature of peptide immunogenicity.
Related to the issue of design for catalysis is a
long-standing project on the characterization and redesign of the Fv fragment
of a catalytic antibody (in collaboration with Drs. Richard Lerner and
A project initiated in collaboration with scientists from
Novartis obtained a number of exceptionally exciting results. Resonance
assignments and a solution structure for LFA-1 have been completed (107, 111);
these results were used directly by Dr. Uli Hommel of Novartis Basel to screen
compounds for binding. Several promising new leads have already arisen from
this work. Our interest in this system is in the understanding of the
interactions between LFA-1 and its physiological partner ICAM-1, in parallel
with a collaborative effort with Dr. Bruce Cunningham to probe the interactions
between the immunoglobulin-like domains of NCAM (99,135). These projects
illustrate the excellent sensitivity of the NMR method as a tool to probe
protein-protein interactions: the NMR spectrum is used directly to map the
sites of interaction.
I have recently become involved in the collaborative efforts
in Dr. Peter Wright’s lab, investigating the mechanisms of transcriptional
activation. This work ties in well with the protein-interaction theme of my
research. It is also highly relevant to the work on unfolded proteins, since a
number of transcriptional activation domains are unfolded or molten-globular in
the absence of their physiological ligands (100). I have been particularly
involved in the resonance assignment and structure determination of a number of
interaction domains; a number of publications have resulted from these
collaborative projects (81, 86, 88, 93, 98, 102, 108, 113, 114, 118, 121, 122,
123, 124, 138, 141, 142, 147, 148, 152, 154, 157, 161, 163, 164, 167, 168, 171,
173, 181, 182, 186, 193, 194, 195, 196, 199, 200, 213, 214, 215).
1973-1976 Tutor, Department of Inorganic Chemistry,
1977-1978 Postdoctoral Fellow, Department of Biology,
Massachusetts Institute of Technology,
1979-1984 UNESCO Lecturer,
1984-1988 Research Associate, Department of Molecular
Biology, The Scripps Research Institute.
1988-1992 Assistant Member, Department of Molecular Biology,
The Scripps Research Institute.
1992-1997 Associate Professor, Department of Molecular
Biology, The Scripps Research Institute.
1997-2001 Associate Professor with Tenure, Department of
Molecular Biology, The Scripps Research Institute
2001-Present Professor, Department of Molecular Biology, The
Scripps Research Institute
1971 Roslyn Flora Goulston Prize for Biochemistry, Faculty
of Science, University of Sydney.
1977-1978 Postdoctoral Award, Damon Runyon-Walter Winchell Cancer Fund.
2009 Awarded D.Sc., Faculty of Science, University of Sydney.
2010 Distinguished Scientist Award, San Diego Section of the American Chemical
Society.
Last revised: April 30, 2012